News from Mayo Clinic

2015

July 13, 2017
References
  1. Ferri FF. Barrett's esophagus. In: Ferri's Clinical Advisor 2017. Philadelphia, Pa.: Elsevier; 2017. https://www.clinicalkey.com. Accessed Feb. 17, 2017.
  2. Spechler SJ, et al. Barrett's esophagus: Epidemiology, clinical manifestations, and diagnosis. http://www.uptodate.com/home. Accessed Feb. 17, 2017.
  3. Shaheen NJ, et al. ACG clinical guideline: Diagnosis and management of Barrett's esophagus. American Journal of Gastroenterology. 2016;111:30.
  4. Barrett's Esophagus. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/digestive-diseases/barretts-esophagus/all-content. Accessed Feb. 19, 2017.
  5. Feldman M, et al. Barrett's esophagus. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 10th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed Feb. 17, 2017.
  6. Hu Q, et al. Proton pump inhibitors do not reduce the risk of esophageal adenocarcinoma in patients with Barrett's esophagus: A systematic review and meta-analysis. PLoS One. 2017;12:1.
  7. Krishnamoorthi R, et al. Risk of recurrence of Barrett's esophagus after successful endoscopic therapy. Gastrointestinal Endoscopy. 2016;83:1090.
  8. Brown A. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Jan. 25, 2017.